Shiga toxin-1 regulation of cytokine production by human proximal tubule cells

Kidney Int. 1998 Oct;54(4):1093-106. doi: 10.1046/j.1523-1755.1998.00118.x.

Abstract

Background: Interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor (TNF) levels are elevated in kidneys of patients with post-diarrheal hemolytic uremic syndrome (D+HUS) and may contribute to renal dysfunction. The renal cellular sources of these inflammatory cytokines in D+HUS are largely unknown, however, the proximal tubule has emerged as a potentially important candidate. Since Shiga toxin-1 (Stx-1) has been implicated in the genesis of D+HUS, we examined the effect of Stx-1 on cytokine production by human proximal tubule cells.

Methods: Stx-1 cytotoxicity, protein synthesis inhibition, and effect on IL-1, IL-6, and TNF protein release and mRNA levels were determined. The effect of another protein synthesis inhibitor, cycloheximide (CHX), on these parameters was also evaluated.

Results: Stx-1 greatly increased TNF release and mRNA levels while CHX, at concentrations that produced similar inhibition of protein synthesis, had no effect on TNF production. In contrast, Stx-1 and CHX caused comparable elevations in IL-1 release and mRNA accumulation. Stx-1 and CHX also stimulated IL-6 mRNA accumulation, but only at concentrations that either were cytotoxic or substantially blocked protein synthesis. Finally, lipopolysaccharide, which is likely to be elevated in the circulation of patients with D+HUS, had no effect alone, but synergized with Stx-1 to increase IL-1 production.

Conclusions: These results indicate that Stx-1 stimulates proximal tubule inflammatory cytokine production and that this effect is due partially to nonspecific induction of mRNA levels as well as activation of Stx-1-specific mechanisms.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Bacterial Toxins / toxicity*
  • Base Sequence
  • Cell Death / drug effects
  • Cells, Cultured
  • Cycloheximide / toxicity
  • Cytokines / biosynthesis*
  • Cytokines / genetics
  • DNA Primers / genetics
  • Hemolytic-Uremic Syndrome / etiology
  • Hemolytic-Uremic Syndrome / genetics
  • Hemolytic-Uremic Syndrome / physiopathology
  • Humans
  • Inflammation Mediators / metabolism
  • Interleukin-1 / biosynthesis
  • Interleukin-1 / genetics
  • Interleukin-6 / biosynthesis
  • Interleukin-6 / genetics
  • Kidney Tubules, Proximal / drug effects*
  • Kidney Tubules, Proximal / physiology*
  • Lipopolysaccharides / toxicity
  • Protein Biosynthesis
  • Protein Synthesis Inhibitors / toxicity
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Shiga Toxins
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • Bacterial Toxins
  • Cytokines
  • DNA Primers
  • Inflammation Mediators
  • Interleukin-1
  • Interleukin-6
  • Lipopolysaccharides
  • Protein Synthesis Inhibitors
  • RNA, Messenger
  • Shiga Toxins
  • Tumor Necrosis Factor-alpha
  • Cycloheximide